The Aflac Cancer & Blood Disorders Center of Childrens Healthcare of Atlanta and the Emory University Department of Pediatrics invites interested applicants for the position of an Aflac Leukemia/Lymphoma Clinician. The Aflac Cancer & Blood Disorders Center provides a rich and collaborative environment for basic, clinical and translational research and boasts a diverse faculty.
The Leukemia and Lymphoma Program is an integral component of the Aflac Cancer & Blood Disorders Center, and currently includes 21 faculty members, 9 of whom are primarily basic research-focused. Ideal candidates will have a strong record of demonstrated clinical expertise caring for pediatric leukemia and lymphoma patients. A track record of involvement in pediatric cancer clinical trials is required. Aflac faculty are part of the Winship Comprehensive cancer Institute and are members of the faculty of the Emory University School of Medicine. The Aflac Cancer & Blood Disorders Center has close affiliations with research investigators within the Winship Cancer Institute, Emory University, and the Georgia Institute of Technology, and a willingness to collaborate across departmental or center boundaries is essential.
About the Aflac Cancer & Blood Disorders Center
The successful candidate will join one of the strongest pediatric hematology/oncology programs in the country.
- In 2021, the Aflac Cancer & Blood Disorders Center was ranked No. 6 in the nation for Pediatric Cancer by US News and World Report
- We are home to one of the largest pediatric cancer programs in the nation, which follows more than 800 children and young adults with leukemia and lymphoma each year
- Each year our team cares for more than 150 newly diagnosed leukemia and lymphoma patients using a variety of treatment protocols, including blood and marrow transplant (BMT), hematopoietic stem cell transplant, chimeric antigen receptor (CAR)-T therapy, and Phase I and II clinical trials for patients whose cancer has relapsed or is not responding to treatment
- The Aflac Cancer & Blood Disorders Center has 115 faculty and 35 Advance Practice Providers (APPs), conducting basic, translational, cooperative group and investigator-initiated clinical research related to pediatric oncology and hematology disorders, with expertise in leukemias, lymphomas, brain tumors, neuroblastoma, sarcomas, rare tumors, renal tumors, CAR T-cell therapies, cancer survivorship, health services research, hemoglobinopathies and hemophilia.
- More than 7,000 children with cancer and blood disorders are treated annually at the Aflac Cancer & Blood Disorders Center
- The Aflac pediatric oncology program sees ~500 new cancer diagnoses each year. Aflac is the pediatric component of the Winship Cancer Institute of Emory University.
- The Aflac pediatric hematology program is one of the largest in the country (including >2,000 active patients with sickle cell disease, and 600 with bleeding or clotting disorders)
- The Aflac blood and marrow transplantation program performs ~80 transplants each year, and is one of the leaders in curative therapies for hemoglobinopathies.
- In 2020, Aflac faculty generated $21.5M in extramural funding, including more than $12.3M from the NIH
- The Aflac fellowship program accepts 6 fellows each year for intensive clinical and research training in pediatric hematology/oncology. We are one of the few pediatric programs with an NIH-funded T32 training grant in non-malignant hematology
- The Aflac Developmental Therapeutics Program includes Leukemia and Lymphoma faculty from the high-risk leukemia team and offers a wide portfolio of clinical trials from cooperative groups, industry partners, and investigator-initiated studies, and has a larger referral base in the southeastern United States. Aflac is a member of the COG Pediatric Early Phase Clinical Trials Network (PEP-CTN), NANT, TACL, and PBTC.
- The MIBG and Relapsed Neuroblastoma Program is the largest in the southeast and has treated ~100 patients with therapeutic MIBG since its inception in 2013.
- Aflac is a leading contributor to the Childrens Oncology Group, having been #1 in therapeutic trial enrollments for the past 2 years and annually in the top 4.
This position will allow a wealth of opportunities for research and quality initiative collaborations within the Department of Pediatrics, with Emorys NCI-designated cancer center (Winship Cancer Institute), as well as with Emory basic science departments, the Rollins School of Public Health, the American Cancer Society (located in Atlanta), the Centers for Disease Control and Prevention and Georgia Institute of Technology.
Successful candidates:
- Will have MD, MD/PhD, or DO degrees
- Must be Board Certified in Pediatric Hematology-Oncology
- Must be currently licensed as a physician and eligible for licensure as a physician in the State of Georgia
- Will be expected to work in a collaborative fashion conducting nationally recognized research in pediatric oncology
- Will have a history of clinical excellence/achievement
- Will have a strong history of mentorship of trainees and junior faculty to support growth in research and scholarship
Salary and rank of Assistant Professor, Associate Professor or Professor at Emory University School of Medicine will be commensurate with experience and accomplishments. The primary focus of this position will be an emphasis on clinical service and administrative duties.
Additional Information:
The Emory + Childrens Pediatric Institute is an affiliation between Emory University and Childrens Healthcare of Atlanta that is improving the lives of children in Georgia and beyond. The Pediatric Institute combines the unique strengths and resources of each institution in support of our three-part academic missions of providing outstanding clinical care, conducting innovative basic science discovery and clinical research, and coordinating exceptional education of the future healthcare workforce.
Our physicians, researchers, and educators have created a model where leadership, commitment and quality are fundamental components of success. Together, we are transforming pediatrics by achieving new levels of clinical excellencedriven by research, teaching and wellness. We look forward to our future together.